Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Anticimex Innovation Center A/S

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.9% 1.9%   Bankruptcy risk   0.5% 2.2% 4.2% 4.3% 0.6% 2.7% 9.0% 9.0%   Credit score (0-100)   98 67 48 46 98 54 7 7   Credit rating   AA BBB BB BB A BB B B   Credit limit (kDKK)   4,449.7 1.5 0.0 0.0 8,959.5 0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   33,093 32,558 31,396 41,578 88,001 42,087 0.0 0.0   EBITDA   12,783 4,857 -2,342 -1,788 54,616 -28.3 0.0 0.0   EBIT   10,702 4,857 -2,342 -1,788 34,968 -29,678 0.0 0.0   Pre-tax profit (PTP)   10,586.8 3,383.0 -1,181.0 -1,566.0 29,190.0 -48,434.4 0.0 0.0   Net earnings   8,255.5 3,383.0 -1,181.0 -1,566.0 24,208.2 -37,265.6 0.0 0.0   Pre-tax profit without non-rec. items   10,587 4,857 -2,342 -1,788 29,190 -48,434 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   3,368 0.0 0.0 0.0 18,827 33,659 0.0 0.0   Shareholders equity total   34,143 37,526 36,345 34,779 58,987 21,722 -69,669 -69,669   Interest-bearing liabilities   1,983 0.0 0.0 0.0 162,701 261,851 69,874 69,874   Balance sheet total (assets)   55,625 76,919 113,830 195,787 315,287 329,689 205 205   Net Debt   1,906 0.0 0.0 0.0 162,701 261,851 69,874 69,874     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   33,093 32,558 31,396 41,578 88,001 42,087 0.0 0.0   Gross profit growth   -22.8% -1.6% -3.6% 32.4% 111.7% -52.2% -100.0% 0.0%   Employees   48 0 0 0 65 74 0 0   Employee growth %   9.1% -100.0% 0.0% 0.0% 0.0% 13.8% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   55,625 76,919 113,830 195,787 315,287 329,689 205 205   Balance sheet change%   41.2% 38.3% 48.0% 72.0% 61.0% 4.6% -99.9% 0.0%   Added value   12,782.8 4,857.0 -2,342.0 -1,788.0 34,968.3 -28.3 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   13,547 -23,245 0 0 96,775 2,070 -147,937 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 -1.0 -2.0 1.0 -1.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   32.3% 14.9% -7.5% -4.3% 39.7% -70.5% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   22.8% 7.3% -2.5% -1.2% 17.0% -8.5% 0.0% 0.0%   ROI %   32.7% 8.3% -2.5% -1.2% 19.7% -10.1% 0.0% 0.0%   ROE %   27.5% 9.4% -3.2% -4.4% 51.6% -92.3% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   57.9% 100.0% 100.0% 100.0% 18.7% 6.6% -99.7% -99.7%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   14.9% 0.0% 0.0% 0.0% 297.9% -924,649.3% 0.0% 0.0%   Gearing %   5.8% 0.0% 0.0% 0.0% 275.8% 1,205.5% -100.3% -100.3%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   24.6% 0.0% 0.0% 0.0% 17.4% 9.9% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.1 0.0 0.0 0.0 0.4 0.2 0.0 0.0   Current Ratio   1.8 0.0 0.0 0.0 0.8 0.6 0.0 0.0   Cash and cash equivalent   76.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   14,076.5 0.0 0.0 0.0 -37,931.0 -116,559.9 -34,937.0 -34,937.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   266 0 0 0 538 -0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   266 0 0 0 840 -0 0 0   EBIT / employee   223 0 0 0 538 -401 0 0   Net earnings / employee   172 0 0 0 372 -504 0 0